EE+ POEM Archive
PSK9 inhibitor alirocumab reduces nonfatal MI in patients after acute coronary syndrome, but at high cost (ODYSSEY OUTCOMES)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "PSK9 Inhibitor Alirocumab Reduces Nonfatal MI in Patients After Acute Coronary Syndrome, but at High Cost (ODYSSEY OUTCOMES)." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314667/all/PSK9_inhibitor_alirocumab_reduces_nonfatal_MI_in_patients_after_acute_coronary_syndrome__but_at_high_cost__ODYSSEY_OUTCOMES_.
PSK9 inhibitor alirocumab reduces nonfatal MI in patients after acute coronary syndrome, but at high cost (ODYSSEY OUTCOMES). In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314667/all/PSK9_inhibitor_alirocumab_reduces_nonfatal_MI_in_patients_after_acute_coronary_syndrome__but_at_high_cost__ODYSSEY_OUTCOMES_. Accessed December 5, 2023.
PSK9 inhibitor alirocumab reduces nonfatal MI in patients after acute coronary syndrome, but at high cost (ODYSSEY OUTCOMES). (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314667/all/PSK9_inhibitor_alirocumab_reduces_nonfatal_MI_in_patients_after_acute_coronary_syndrome__but_at_high_cost__ODYSSEY_OUTCOMES_
PSK9 Inhibitor Alirocumab Reduces Nonfatal MI in Patients After Acute Coronary Syndrome, but at High Cost (ODYSSEY OUTCOMES) [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2023 December 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314667/all/PSK9_inhibitor_alirocumab_reduces_nonfatal_MI_in_patients_after_acute_coronary_syndrome__but_at_high_cost__ODYSSEY_OUTCOMES_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - PSK9 inhibitor alirocumab reduces nonfatal MI in patients after acute coronary syndrome, but at high cost (ODYSSEY OUTCOMES)
ID - 1314667
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314667/all/PSK9_inhibitor_alirocumab_reduces_nonfatal_MI_in_patients_after_acute_coronary_syndrome__but_at_high_cost__ODYSSEY_OUTCOMES_
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
